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Abstract
Background Postoperative fascial dehiscence and open
abdomen are severe postoperative complications and are
associated with surgical site infections, fistula, and hernia
formation at long-term follow-up. This study was designed
to investigate whether intraperitoneal implantation of a
composite prosthetic mesh is feasible and safe.
Methods A total of 114 patients with postoperative fas-
cial dehiscence and open abdomen who had undergone
surgery between 2001 and 2009 were analyzed retrospec-
tively. Contaminated (wound class 3) or dirty wounds
(wound class 4) were present in all patients. A polypro-
pylene-based composite mesh was implanted intraperito-
neally in 51 patients, and in 63 patients the abdominal wall
was closed without mesh implantation. The primary end-
point was incidence of incisional hernia, and the incidence
of enterocutaneous fistula was a secondary endpoint.
Results The incidence of enterocutaneous fistulas after
wound closure post-fascial dehiscence (13% vs. 6% with-
out and with mesh, respectively) or post-open abdomen
(22% vs. 28% without and with mesh, respectively) was
not significantly different. The incidence of incisional
hernia was significantly lower with mesh implantation
compared with no-mesh implantation in both contaminated
(4% vs. 28%; p = 0.025) and dirty abdominal cavities (5%
vs. 34%; p = 0.01).
Conclusions Intra-abdominal contamination is not a con-
traindication for intra-abdominal mesh implantation. The
incidence of enterocutaneous fistula is not elevated despite
the presence of contamination. The rate of incisional hernias
is significantly reduced after intraperitoneal mesh implan-
tation for postoperative fascial dehiscence or open abdomen.
Introduction
Fascial dehiscence with bowel eventration and open abdo-
men are potential sequelae of abdominal surgery and are
associated with significant morbidity and cost. The incidence
of fascial dehiscence in patients with various degrees of
wound contamination is as high as 3% and is associated with
mortality as high as 44% [1–5]. Reoperations for such
wound-related complications are associated with an inci-
dence of incisional hernia as high as 54% [6]. Numerous
strategies have been proposed to reduce wound dehiscence
and incisional hernia, including delayed reconstruction using
flaps, lateral incisions, or dynamic systems [7–10]. In a
recent publication, a combination of vacuum- and mesh-
mediated traction was shown to be safe and reduce the
incidence of large planned ventral hernia [11]. However,
long-term results are missing and a high incidence of inci-
sional hernia is expected. In this study, we present our results
with primary mesh implantation as a new option for these
difficult situations. This strategy was introduced to prevent
early and late complications, such as recurrent fascial
dehiscence and incisional hernia. However, mesh implan-
tation may be associated with complications, such as chronic
infection and enterocutaneous fistula formation [12, 13].
This study was designed to determine if implantation of a
polypropylene-based composite mesh is safe in such clinical
scenarios that are associated with contaminated or dirty
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wounds and assess the long-term follow up of these patients,
especially regarding hernia formation.
Methods
Patient characteristics
All patients with acute postoperative fascial dehiscence or
open abdomen treated at our institution between January
2001 and December 2009 were recorded in a digital data-
base and analyzed retrospectively. To assess and compare
preoperative risk factors, the surgical risk scale (SRS) was
calculated as described previously [14]. By definition of the
Centers of Disease Control and Prevention, fascial dehis-
cence and open abdomen are contaminated (wound class 3;
open wounds, acute nonpurulent infection) or dirty wounds
(wound class 4; active infection present) [15]. Approval for
the study was obtained from the local ethical committee.
Surgical technique
Patients were divided into four groups based on the sur-
gical techniques used for abdominal closure, as shown in
Fig. 1. When closure of the abdominal wall was technically
possible, the abdominal fascia was sutured using PDS
loop 1 sutures (Ethicon Sarl, Neuchatel, Switzerland) or
additional Vicryl strings (Ethicon Sarl, Neuchatel, Swit-
zerland) (group: fascial closure without mesh implanta-
tion). In the second group (fascial closure with mesh
implantation), the mesh was placed intraperitoneally and
fixed with single knot sutures (Prolene 2-0, Ethicon Sarl,
Neuchatel, Switzerland), endosurgical staples (Protack,
Covidien AG, Wollerau, Switzerland), or a combination of
both. The mesh consisted of nonabsorbable polypropylene
composite material (Parietene, Parietex, Covidien AG,
or Dynamesh, Laubscher & Co AG, Ho¨lstein, Switzer-
land). In all patients with open abdomen, a fascial closure
was attempted intraoperatively but was technically not
possible. Patients who underwent open abdomen without
mesh implantation were treated with vacuum-assisted clo-
sure (VAC, KCI medical GmbH, Ru¨mlang, Switzerland)
alone. Abdominal VAC dressing was placed intraperito-
neally, and VAC was performed using negative pressure
between 25 and 125 mmHg and was subsequently reduced
in magnitude. In the last group (open abdomen with mesh
implantation), the same type of mesh was sutured to the
peritoneum followed by wound closure with VAC.
Follow-up
Clinical follow-up investigations were conducted on an
outpatient basis by the responsible surgeon or the patient’s
general practitioner. When applicable, date and cause of
death were recorded.
Statistics
All statistical tests were performed by using SPSS Statistics
(Version 17.0.0, SPSS Inc., Chicago, IL). Categorical data
were analyzed with the Fisher’s exact test; continuous data
were analyzed with Student’s t test. A cutoff value of
p \ 0.05 was used to determine statistical significance.
Results
Patient characteristics and risk factors were similar
between the groups (Table 1). Indications for the initial
operations included elective, emergent, or urgent opera-
tions for tumors, hollow organ perforation, acute or chronic
inflammation of visceral organs, incarcerated hernia, and
mechanical ileus (Table 2).
Early postoperative complications were compared between
no mesh and mesh implantation in patients with wound
class 3 (Table 3) and wound class 4 (Table 4). The incidence
of incisional hernia was significantly lower with mesh
implantation than without it, irrespective of wound class.
The incidence of enterocutaneous fistulas did not differ
between the mesh and nonmesh groups. Hospital stay was
significantly longer in patients with wound class 4 compared
with those with wound class 3 (50 ± 39 days vs. 32 ± 19
days, respectively; p = 0.002).
Subgroup analysis was performed of patients with fascial
closure (Table 5) and for patients with open abdomen
(Tables 6). The incidence of incisional hernia was significantly
Fig. 1 Surgical techniques used in this study. A complicated
abdominal closure was defined as closure after fascial dehiscence or
open abdomen
1558 World J Surg (2012) 36:1557–1561
123
lower with mesh implantation than without it in both the sub-
group of fascial closure (3% vs. 22%; p = 0.02) and the
subgroup of patients with open abdomen (6% vs. 100%;
p\0.001).
Discussion
The results of this study reveal the safety of intraperitoneal
mesh implantation despite the presence of contamination.
In particular, the study shows a significantly reduced
incidence of abdominal wall hernia without an increased
risk of enterocutaneous fistula formation for critical
abdominal wounds that are characterized by intraperitoneal
infection and complicated abdominal wound closure.
In this series, only patients with postoperative fascial
dehiscence or open abdomen were included. A total of 22%
of patients developed incisional hernias after fascial clo-
sure without mesh implantation, and 90% of these patients
underwent operative hernia repair during follow-up. Such
incidence of incisional hernia is consistent with previous
findings, although higher rates have been observed [4, 6,
16]. In the present series, mesh implantation with fascial
closure reduced the incidence of incisional hernia signifi-
cantly without additional morbidity.
Open abdomen may be necessary under specific condi-
tions in patients with generalized peritonitis or for post-
traumatic damage control [5, 17, 18]. The resulting
abdominal wall defect after open abdomen can be quite
large, and subsequent reconstruction may be associated with
high additional morbidity [19]. Except for one patient, no
reconstructive surgery was necessary after mesh implanta-
tion for open abdomen. This patient developed a parapros-
thetical hernia after open abdomen with mesh implantation
due to an undersized mesh, which had to be replaced with a
larger mesh 1 week after surgery for open abdomen. All
patients with open abdomen without mesh implantation had,
by definition, an incisional hernia, and 50% of these patients
underwent operative repair of their hernia.
Enterocutaneous fistula formation is a potentially seri-
ous complication in patients with postoperative fascial
dehiscence or open abdomen [18]. In the present study, the
incidence of enterocutaneous fistulas was higher after open
abdomen than after direct fascial closure. However, the
main finding of this study is that the incidence of entero-
cutaneous fistulas is not associated with the presence of
intraabdominal mesh. One group has shown an association
of intraperitoneal mesh implantation with the formation of
enterocutaneous fistula [20]. However, in that study no
composite meshes were used.
In patients undergoing fascial closure, the observed
incidence of fistula formation (13.3% without mesh vs.
8.8% with mesh) is comparable to that observed in previ-
ous studies [21, 22]. The incidence of fistulas after open
abdomen (22% without mesh vs. 28% with mesh) also is
comparable to that in previous studies [23–26].
All of our meshes in patients with open abdomen were
in contact with the environment and healing by secondary
intention was possible. Mesh infection as reported in other
series potentially prolonged healing [27]. However, in the
current series, we did not observe an increased incidence of
infectious complications associated with mesh implanta-
tion. No mesh-explantation due to infection was required.
Table 1 Characteristics of all patients who underwent fascial closure
or open abdomen with or without mesh implantation
No mesh
(n = 63)
Mesh
(n = 51)
P valuea
Male 37 (58.7) 32 (62.7) 0.703
Age (year)* 61.3 (22–85) 64.3 (22–86) 0.059b
BMI [ 30 kg/m2 18 (28.6) 8 (15.7) 0.12
Malignancy within past
5 years
20 (31.7) 27 (52.9) 0.035
Diabetes mellitus 7 (11.1) 7 (13.7) 0.777
Cardiovascular disease 16 (25.4) 15 (29.4) 0.676
COPD 12 (19.0) 15 (29.4) 0.268
Immunosuppression 9 (14.3) 10 (19.6) 0.462
ASA score 3 or 4 45 (81.8) 38 (86.4) 0.833
SRS C 10 27 (49.1) 28 (63.6) 0.258
Data in parentheses are percentages unless otherwise indicated; * data
are median (range)
BMI body mass index; COPD chronic obstructive pulmonary disease;
ASA American Society of Anesthesiologists score; SRS surgical risk
scale
a Fisher exact test; b Students t test
Table 2 Indications for the primary operation
No mesh
(n = 63)
Mesh
(n = 51)
P value*
Malignant tumor 15 (23.8) 18 (35.3) 0.215
Hollow organ perforation 22 (34.9) 14 (27.5) 0.424
Acute or chronic inflammation 11 (17.5) 4 (7.8) 0.168
Incarcerated hernia and
mechanical ileus
1 (1.6) 3 (5.9) 0.323
Hemorrhage 1 (1.6) 2 (3.9) 0.586
Elective hernia repair 1 (1.6) 2 (3.9) 0.586
Intestinal ischemia 0 (0.0) 2 (3.9) 0.198
Transplantation 2 (3.2) 1 (2) 0.414
Vascular surgery 2 (3.2) 1 (2) 0.414
Trauma 1 (1.6) 0 (0) 1
Others 7 (11.1) 4 (7.8) 0.752
Data in parentheses are percentages
* Fisher’s exact test
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A limitation of this study was its retrospective design,
and we cannot exclude selection bias determined by the
indication for mesh implantation, such as existing con-
tamination or fascial retraction. However, the conditions
investigated are rare events, limiting the feasibility of a
prospective randomized trial. The groups were comparable
in terms of patient characteristics, risk factors, and
comorbidities. Furthermore, comorbidities, general health
status, type, and invasiveness of the procedure were similar
as assessed by the surgical risk scale [14]. These similari-
ties between groups helped to reduce the possibility that
confounding factors caused the observed differences
associated with mesh versus nonmesh procedures. The
estimated mortality associated with a surgical risk scale of
10 is approximately 19% and increases to 90% with the
maximum score of 14 [28]. Most patients in this study had
a surgical risk scale of 10 and higher and our overall
mortality rate was 15.7%.
In conclusion, the implantation of nonabsorbable
meshes for postoperative fascial dehiscence or open
abdomen, despite a contaminated or dirty abdomen, is
associated with a reduced incidence of incisional abdomi-
nal wall hernias and should be considered as a therapeutic
option in these critically ill patients. Overall mortality rates
Table 4 Perioperative and postoperative results of patients with
wound class 4 (dirty abdomen)
No mesh
(n = 35)
Mesh
(n = 22)
P valueb
Perioperative results
Time between primary
operation and abdominal
wall closure (days)*
11 (2–65) 11 (4–28) 0.175c
VAC-therapy, n 30 (85.7) 19 (86.4) 1
Negative pressure of VAC
(mmHg)*
75 (25–125) 75 (50–125) 0.496
Hospital stay (days)a 53 (±44.3) 47 (±30.3) 0.544c
ICU stay (days)a 10 (± 15.5) 5 (± 9.4) 0.108c
Early complications
Enterocutaneous fistula, n 6 (17.1) 3 (13.6) 1
30 day mortality 8 (22.9) 4 (18.2) 0.75
Follow-up
Months of follow-upa 10 (±15.7) 7 (±7.7) 0.372c
Overall mortality 12 (34.3) 5 (22.7) 0.391
Incidence of incisional
hernia, n
12 (34.3) 1 (4.5) 0.01
Operation for incisional
hernia, n
11 (31.4) 0 (0) 0.004
VAC vacuum-assisted closure; ICU intensive care unit
Data in parentheses are percentages unless otherwise indicated
* data are median (range)
a data are mean (standard deviation)
b Fisher exact test
c Student’s t test
Table 3 Perioperative and postoperative results of patients with
wound class 3 (contaminated abdomen)
No mesh
(n = 29)
Mesh
(n = 28)
P valueb
Perioperative results
Time between primary
operation and abdominal
wall closure (days)*
10 (1–229) 12 (4–82) 0.594c
VAC-therapy, n 16 (55.2) 21 (75) 0.167
Negative pressure of VAC
(mmHg)*
88 (40–125) 75 (50–125) 0.831
Hospital stay (days)a 28 (±17.9) 36 (±20.8) 0.146c
ICU stay (days)a 6 (±11.3) 3 (±6.9) 0.18c
Early Complications
Enterocutaneous fistula, n 5 (17.2) 3 (10.7) 0.706
30 day mortality 5 (17.2) 1 (3.6) 0.194
Follow-up
Months of follow-upa 17 (± 24) 8 (± 11.7) 0.079c
Overall mortality 10 (34.5) 9 (32.1) 1
Incidence of incisional
hernia, n
8 (27.6) 1 (3.6) 0.025
Operation for incisional
hernia, n
7 (24.1) 1 (3.6) 0.052
VAC vacuum-assisted closure; ICU intensive care unit
* Data are median (range)
a Data are mean (standard deviation)
b Fisher exact test
c Student’s t test
Table 5 Subgroup analysis of patients with fascial closure
No mesh
(n = 45)
Mesh
(n = 33)
P valuea
Wound class 3
(contaminated), n
23 (51.1) 22 (66.7) 0.246
Wound class 4 (dirty), n 22 (48.9) 11 (33.3) 0.246
Early complications
Enterocutaneous fistula 6 (13.3) 2 (6.1) 0.456
Length of hospital stay
(days)*
36.8 (±32.4) 35.7 (±22.3) 0.859b
30-days mortality 7 (15.6) 1 (3) 0.129
Follow-up
Months of follow-up* 14 (±21.3) 8 (±10.5) 0.078b
Overall mortality 10 (22.2) 7 (21.2) 1
Incidence of incisional
hernia, n
10 (22.2) 1 (3) 0.02
Operation for incisional
hernia, n
9 (20) 0 (0) 0.008
* Data in parentheses are percentages unless otherwise indicated
Data are mean (standard deviation)
a Fisher’s exact test
b Student’s t test
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and enterocutaneous fistula formation rates were not
influenced by the use of mesh.
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Table 6 Subgroup analysis of patients with open abdomen
No mesh
(n = 18)
Mesh
(n = 18)
P valuea
Wound class 3
(contaminated), n
6 (33.3) 6 (33.3) 1
Wound class 4 (dirty), n 12 (66.7) 12 (66.7) 1
Early complications
Enterocutaneous fistula 4 (22.2) 5 (27.8) 1
Length of hospital stay
(days)*
50 (±43.3) 54 (±31.9) 0.784b
30 days mortality 6 (33.3) 4 (22.2) 0.711
Follow-up
Months of follow-up* 10 (±16.2) 7 (±9.1) 0.439b
Overall mortality 11.0 (61.1) 8.0 (44.4) 0.505
Incidence of incisional
hernia, n
18 (100) 1 (5.6) \0.001
Operation for incisional
hernia, n
9 (50) 1 (5.6) 0.007
Data in parentheses are percentages unless otherwise indicated
* Data are mean (standard deviation)
a Fisher exact test
b Student’s t test
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